CN106389859A - 一种用于治疗丛集性头痛的中药组合物 - Google Patents
一种用于治疗丛集性头痛的中药组合物 Download PDFInfo
- Publication number
- CN106389859A CN106389859A CN201610975253.XA CN201610975253A CN106389859A CN 106389859 A CN106389859 A CN 106389859A CN 201610975253 A CN201610975253 A CN 201610975253A CN 106389859 A CN106389859 A CN 106389859A
- Authority
- CN
- China
- Prior art keywords
- parts
- herba
- chinese medicine
- medicine composition
- cluster headache
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000003814 drug Substances 0.000 title claims abstract description 57
- 208000006561 Cluster Headache Diseases 0.000 title claims abstract description 28
- 208000018912 cluster headache syndrome Diseases 0.000 title claims abstract description 27
- 239000000203 mixture Substances 0.000 title claims abstract description 22
- 241001533451 Ajuga ciliata Species 0.000 claims abstract description 16
- 241000921449 Rhodobryum roseum Species 0.000 claims abstract description 15
- 241000237636 Pheretima Species 0.000 claims description 16
- 241000255978 Antheraea pernyi Species 0.000 claims description 12
- 244000088424 Cyperus michelianus Species 0.000 claims description 12
- 210000002216 heart Anatomy 0.000 claims description 8
- 244000025254 Cannabis sativa Species 0.000 claims description 6
- 230000000694 effects Effects 0.000 abstract description 16
- 208000002193 Pain Diseases 0.000 abstract description 14
- 230000036407 pain Effects 0.000 abstract description 13
- 238000000034 method Methods 0.000 abstract description 5
- 238000010521 absorption reaction Methods 0.000 abstract description 4
- 208000024891 symptom Diseases 0.000 abstract description 3
- 230000007246 mechanism Effects 0.000 abstract description 2
- 206010067484 Adverse reaction Diseases 0.000 abstract 1
- 241001313869 Arundina graminifolia Species 0.000 abstract 1
- 241000222666 Boerhavia diffusa Species 0.000 abstract 1
- 241000255789 Bombyx mori Species 0.000 abstract 1
- 240000001723 Entada phaseoloides Species 0.000 abstract 1
- 241001558017 Gynura Species 0.000 abstract 1
- 241001571723 Lysimachia insignis Species 0.000 abstract 1
- 241001633680 Polygonatum odoratum Species 0.000 abstract 1
- 241000270295 Serpentes Species 0.000 abstract 1
- 241000292546 Taraxacum mongolicum Species 0.000 abstract 1
- 230000006838 adverse reaction Effects 0.000 abstract 1
- 241001233061 earthworms Species 0.000 abstract 1
- 230000008030 elimination Effects 0.000 abstract 1
- 238000003379 elimination reaction Methods 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 230000002787 reinforcement Effects 0.000 abstract 1
- 206010019233 Headaches Diseases 0.000 description 17
- 231100000869 headache Toxicity 0.000 description 17
- 210000004185 liver Anatomy 0.000 description 11
- 229940079593 drug Drugs 0.000 description 9
- 239000000796 flavoring agent Substances 0.000 description 6
- 235000019634 flavors Nutrition 0.000 description 6
- 210000003734 kidney Anatomy 0.000 description 6
- 229920002472 Starch Polymers 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 210000000952 spleen Anatomy 0.000 description 5
- 239000008107 starch Substances 0.000 description 5
- 235000019698 starch Nutrition 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 241000382353 Pupa Species 0.000 description 4
- 206010037660 Pyrexia Diseases 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 230000036461 convulsion Effects 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 239000003440 toxic substance Substances 0.000 description 4
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 3
- 206010010904 Convulsion Diseases 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- 208000019695 Migraine disease Diseases 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 206010027599 migraine Diseases 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000035807 sensation Effects 0.000 description 3
- 235000019615 sensations Nutrition 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 210000003932 urinary bladder Anatomy 0.000 description 3
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 206010010726 Conjunctival oedema Diseases 0.000 description 2
- 208000007882 Gastritis Diseases 0.000 description 2
- 206010019468 Hemiplegia Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 206010044565 Tremor Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- -1 absorption carrier Substances 0.000 description 2
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 230000009191 jumping Effects 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000000541 pulsatile effect Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000000306 recurrent effect Effects 0.000 description 2
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 2
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 206010006002 Bone pain Diseases 0.000 description 1
- 241000208365 Celastraceae Species 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 206010020741 Hyperpyrexia Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 206010034960 Photophobia Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000004680 Rectal Fistula Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 239000004141 Sodium laurylsulphate Substances 0.000 description 1
- 235000000336 Solanum dulcamara Nutrition 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 201000004484 acute conjunctivitis Diseases 0.000 description 1
- 206010001093 acute tonsillitis Diseases 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 206010002156 anal fistula Diseases 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 229960000913 crospovidone Drugs 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 210000003298 dental enamel Anatomy 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 1
- 239000007919 dispersible tablet Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 208000003512 furunculosis Diseases 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 229940071676 hydroxypropylcellulose Drugs 0.000 description 1
- 230000001709 ictal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 229940031703 low substituted hydroxypropyl cellulose Drugs 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 201000003265 lymphadenitis Diseases 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 230000001314 paroxysmal effect Effects 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 description 1
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 230000002226 simultaneous effect Effects 0.000 description 1
- 201000009890 sinusitis Diseases 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/583—Snakes; Lizards, e.g. chameleons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/10—Bryophyta (mosses)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/89—Cyperaceae (Sedge family)
- A61K36/8905—Cyperus (flatsedge)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Insects & Arthropods (AREA)
- Neurosurgery (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种用于治疗丛集性头痛的中药组合物,以重量份表示,所述内服药物包括蛇蜕1~20份、护心草1~20份、玉竹1~20份、白芷1~20份、黄芩1~20份、地龙1~20份、蒲公英1~20份、回心草1~10份、豨莶草1~25份、柞蚕蛹1~20份、老来青1~20份、长杆兰1~20份、榼藤子1~20份、筋骨草1~20份、三张叶1~20份。本发明是基于对丛集性头痛症状机理的认识及治疗原则,采用直接口服的方法,攻补兼施,共具有镇痛、安神的效果,疗效显著,质量容易控制,稳定性好,基本无不良反应,易于吸收、见效快、使用方便、价格低。
Description
技术领域
本发明属于中医药领域,具体是指一种用于治疗丛集性头痛的中药组合物。
背景技术
丛集性头痛是一种发生在头部或左或右、是以头痛暴作、疼痛剧烈、反复发作为特征的搏动性头痛。发作前常有先兆,如眼前闪光、视物模糊、肢体麻木等,可伴恶心、呕吐,安静、黑暗环境内或睡眠后头痛缓解,反复发作特征相似。本病属中医学“头痛”、“头风”、“丛集性头痛”、“偏头风”等范畴。
目前西医只能靠止痛药来缓解疼痛,并无特效药物,而吃止痛药,往往初期有效,吃久了止不住疼痛,或者加大药量,药物的副作用也会随之出现,常见的有胃炎、胃出血、胃溃疡、解热镇痛性肾炎等,甚至会引起药物性头痛。可以说,对于丛集性头痛,现代西医没有办法治愈。
发明内容
本发明的目的是克服传统药物的缺陷,提供一种疗效显著,质量容易控制,稳定性好的用于治疗丛集性头痛的中药组合物。
本发明通过下述技术方案实现:一种用于治疗丛集性头痛的中药组合物,以重量份表示,所述内服药物包括蛇蜕1~20份、护心草1~20份、玉竹1~20份、白芷1~20份、黄芩1~20份、地龙1~20份、蒲公英1~20份、回心草1~10份、豨莶草1~25份、柞蚕蛹1~20份、老来青1~20份、长杆兰1~20份、榼藤子1~20份、筋骨草1~20份、三张叶1~20份。
本发明治疗丛集性头痛的中药组合物中一份的量2~5g,优选一份的量3g。
本发明所述的一种用于治疗丛集性头痛的中药组合物的原料药药理:
蛇蜕:味咸、甘,性平。归肝经。有祛风,定惊,退翳,解毒的作用。
护心草:性味淡辛,性平,无毒。入肝、脾二经。具有行气养血;调经的作用。
玉竹:性甘、淡,平。归心、肺、脾、肾经。利水渗湿,健脾宁心。养阴、润燥、清热、生津、止咳。
白芷:性辛,温。归入肺、脾、胃经。祛风,燥湿,消肿,止痛。治头痛,眉棱骨痛,齿痛,鼻渊,寒湿腹痛,肠风痔漏,赤白带下,痈疽疮疡,皮肤燥痒,疥癣。
黄芩:性味:苦,寒。归入心、肺、胆、大肠经。泻实火,除湿热,止血,安胎。治壮热烦渴,肺热咳嗽,湿热泻痢,黄疸,热淋,吐、衄、崩、漏,目赤肿痛,胎动不安,痈肿疔疮。
地龙:性寒,味咸,归肝、胃、肺、膀胱经,清热平肝、熄风止痉、平喘、利尿、通络除痹。主治高热烦躁、惊痫抽搐、肺热喘咳、热结尿闭、痹痛肢麻、半身不遂,以及疮疡肿毒。高热狂燥,惊风抽搐,风热头痛,目赤、半身不遂等。
蒲公英:性苦甘,寒。归入肝、胃经。清热解毒,利尿散结。治急性乳腺炎,淋巴腺炎,瘰疬,疔毒疮肿,急性结膜炎,感冒发热,急性扁桃体炎,急性支气管炎,胃炎,肝炎,胆囊炎,尿路感染。
回心草:性辛、味苦、平。归肝、肾经。养心安神,清肝明目。用于心悸怔忡,神经衰弱,外用治目赤肿痛。
豨莶草:性味苦、辛,性寒。入归肝、肾经。祛风湿,通经络,清热解毒。
柞蚕蛹:性味甘,性平。归归肝、胃经。生津止渴,止痉。
长杆兰:性味苦,性微寒。入肝、肾、膀胱经,具有清热解毒,祛风利湿,散瘀止痛。
榼藤子:性味辛、苦,性微温。归肾、膀胱经。活血祛风,壮腰固肾。用于风湿关节痛,四肢麻木,跌打损伤,骨折。
三张叶:性辛苦,温,性微温。归膀胱、肺、脾、肝经。祛风通络;行气活血。主风湿痹痛;脘腹疼痛;跌打肿痛。
为优化药物的药物效果,进一步确定,所述蛇蜕10~17份、护心草5~19份、玉竹3~18份、白芷8~19份、黄芩4~11份、地龙5~15份、蒲公英1~14份、回心草4~14份、豨莶草14~20份、柞蚕蛹12~17份、老来青4~17份、长杆兰7~14份、榼藤子6~9份、筋骨草5~19份、三张叶3~17份。
为优化药物的药物效果,进一步确定,所述蛇蜕14份、护心草5份、玉竹4份、白芷16份、黄芩7份、地龙6份、蒲公英12份、回心草12份、豨莶草17份、柞蚕蛹15份、老来青15份、长杆兰5份、榼藤子6份、筋骨草5份、三张叶7份。
为优化药物的药物效果,进一步确定,所述蛇蜕15份、护心草17份、玉竹14份、白芷17份、黄芩4份,地龙10份、蒲公英13份、回心草13份、豨莶草16份、柞蚕蛹12份、老来青16份、长杆兰7份、榼藤子6份、筋骨草5份、三张叶13份。
为优化药物的药物效果,进一步确定,所述蛇蜕13份、护心草18份、玉竹14份、白芷9份、黄芩8份、地龙6份、蒲公英11份、回心草12份、豨莶草15份、柞蚕蛹15份、老来青15份、长杆兰8份、榼藤子8份、筋骨草7份、三张叶6份。
本发明与现有技术相比,具有的优点及有益效果为:
本发明是基于对丛集性头痛症状机理的认识及治疗原则,采用直接口服的方法,攻补兼施,共具有镇痛、安神的效果,疗效显著,质量容易控制,稳定性好,基本无不良反应,易于吸收、见效快、使用方便、价格低。
具体实施方式
下面结合实施例对本发明作进一步地详细说明,但本发明的实施方式不限于此,在不脱离本发明上述技术思想情况下,根据本领域普通技术知识和惯用手段,做出各种替换和变更,均应包括在本发明的范围内。
实施例1:
本实施例所述用于治疗丛集性头痛的中药组合物,以重量份表示,所述内服药物包括蛇蜕5份、护心草3份、玉竹2份、白芷4份、黄芩5份、地龙1份、蒲公英2份、回心草8份、豨莶草1份、柞蚕蛹3份、老来青2份、长杆兰3份、榼藤子2份、筋骨草4份、三张叶3份。
本发明药物的制备方法,包括以下步骤:
(1)将上述全部中药原料药,先行用清水或纯净水浸泡60分钟,浸泡用水量为0.9~1.1L;
(2)将浸泡后的中药原料药物及其浸泡的药水加入到煎药容器中,加盖共同煎熬;
(3)先用武火使煎药容器中药液沸腾,再使用文火熬制30~60分钟,煎药时需搅拌2~3次;
(4)煎煮完成后,加适量清水或纯净水没过药物,进行第二次煎煮,煎煮火候方法同上,煎煮时间30~60分钟;
(5)滤出药液,所获药液即为内服药物。
本发明治疗丛集性头痛的中药组合物中一份的量2~5g,优选一份的量3g。
本发明治疗丛集性头痛的中药组合物可以为片剂、分散片、颗粒剂、胶囊剂或汤剂。
在药剂制备过程中根据需要,可以加入各种药学上可接受的载体。所述的载体包括药学领域常规的稀释剂、赋形剂、填充剂、粘合剂、湿润剂、崩解剂、吸收促进剂、表面活性剂、吸附载体、润滑剂等。本发明的药剂在制备时,可选择的填充剂有:淀粉、糖粉、磷酸钙、糊精、微晶纤维素、乳糖、预胶化淀粉、甘露醇等;可选择的粘合剂有:羧甲基纤维素钠、PVP-K30、羟丙基纤维素、淀粉浆、甲基纤维素、乙基纤维素、羟丙基甲基纤维素、胶化淀粉等;可选择的崩解剂有:干淀粉、交联聚维酮、交联羧甲基纤维素钠、羧甲基淀粉钠、低取代羟丙基纤维素等;可选择的润滑剂有:硬脂酸镁、滑石粉、十二烷基硫酸钠、微粉硅胶等。
上述煎药容器为砂锅、搪瓷或者不锈钢器皿,忌用铁器。
本发明药物的使用方法:直接内服。
实施例2:
本实施例所述用于治疗丛集性头痛的中药组合物,以重量份表示,所述蛇蜕17份、护心草12份、玉竹13份、白芷14份、黄芩5份、地龙6份、蒲公英13份、回心草12份、豨莶草16份、柞蚕蛹13份、老来青14份、长杆兰5份、榼藤子7份、筋骨草17份、三张叶15份。
实施例3:
本实施例所述用于治疗丛集性头痛的中药组合物,以重量份表示,所述蛇蜕14份、护心草5份、玉竹4份、白芷16份、黄芩7份、地龙6份、蒲公英12份、回心草12份、豨莶草17份、柞蚕蛹15份、老来青15份、长杆兰5份、榼藤子6份、筋骨草5份、三张叶7份。
实施例4:
本实施例所述用于治疗丛集性头痛的中药组合物,以重量份表示,所述蛇蜕15份、护心草17份、玉竹14份、白芷17份、黄芩4份,地龙10份、蒲公英13份、回心草13份、豨莶草16份、柞蚕蛹12份、老来青16份、长杆兰7份、榼藤子6份、筋骨草5份、三张叶13份。
实施例5:
本实施例所述用于治疗丛集性头痛的中药组合物,以重量份表示,所述蛇蜕13份、护心草18份、玉竹14份、白芷9份、黄芩8份、地龙6份、蒲公英11份、回心草12份、豨莶草15份、柞蚕蛹15份、老来青15份、长杆兰8份、榼藤子8份、筋骨草7份、三张叶6份。
利用本发明药物针对各种丛集性头痛患者的临床统计资料:
1、一般资料
经过300例患者的临床使用,其中男患者163,女患者137例,用药年龄对象20~60岁。其中最小21岁,最大59岁,平均年龄38岁;轻度丛集性头痛121例,中度丛集性头痛141例,重度丛集性头痛38例。
2、诊断标准
发作性中度到重度搏动性头痛,伴恶心、呕吐或畏光。体力活动使头痛加剧。发作开始时仅为轻到中度的钝痛或不适感,几分钟到几小时后达到严重的搏动性痛或跳痛。约2/3为一侧性头痛,也可为双侧头痛,有时疼痛放射至上颈部及肩部。
3、治疗方法
口服本发明最优技术方案制得的胶囊剂,每天2次,每次4-6粒,7天一疗程,连续服用2个疗程。
典型病例:
1、房某,男,46岁,吉林白城人,头痛5年,患者自诉左侧太阳穴为主,跳痛,睡眠差可诱发,每月疼2~3次,持续性,面热,舌质暗,体大,苔白,脉弦。服用1个疗程后,头痛未发,时有面热,睡眠亦有好转,舌质暗,苔白,脉弦。继续服用1个疗程后,头痛1个月中仅发作1次,较轻,舌质暗,体略大,苔白,脉弦。继续服用1个疗程后,头痛消失,时有面热,舌体大,质红暗,苔白,脉弦滑。3个月后电话随访,头痛再无发作。
2、唐某,女,35岁,青海西宁人,患者自诉阵发性右侧偏头痛2个月,经常心烦,多梦,面色不华,舌苔白腻较厚,质淡,脉细尺软,血压145/105mmHg,用过多种药物治疗,效果很差,无法治愈。后来我院就诊,服用本发明药物,服用1个疗程后,症状基本消失,服用第2个疗程后,偏头痛全愈,随访,至今未复发。
以上所述,仅是本发明的较佳实施例,并非对本发明做任何形式上的限制,凡是依据本发明的技术实质对以上实施例所作的任何简单修改、等同变化,均落入本发明的保护范围之内。
Claims (5)
1.一种用于治疗丛集性头痛的中药组合物,其特征在于:以重量份表示,所述内服药物包括蛇蜕1~20份、护心草1~20份、玉竹1~20份、白芷1~20份、黄芩1~20份、地龙1~20份、蒲公英1~20份、回心草1~10份、豨莶草1~25份、柞蚕蛹1~20份、老来青1~20份、长杆兰1~20份、榼藤子1~20份、筋骨草1~20份、三张叶1~20份。
2.根据权利要求1所述的一种用于治疗丛集性头痛的中药组合物,其特征在于:以重量份表示,所述蛇蜕10~17份、护心草5~19份、玉竹3~18份、白芷8~19份、黄芩4~11份、地龙5~15份、蒲公英1~14份、回心草4~14份、豨莶草14~20份、柞蚕蛹12~17份、老来青4~17份、长杆兰7~14份、榼藤子6~9份、筋骨草5~19份、三张叶3~17份。
3.根据权利要求1所述的一种用于治疗丛集性头痛的中药组合物,其特征在于:以重量份表示,所述蛇蜕14份、护心草5份、玉竹4份、白芷16份、黄芩7份、地龙6份、蒲公英12份、回心草12份、豨莶草17份、柞蚕蛹15份、老来青15份、长杆兰5份、榼藤子6份、筋骨草5份、三张叶7份。
4.根据权利要求1所述的一种用于治疗丛集性头痛的中药组合物,其特征在于:以重量份表示,所述蛇蜕15份、护心草17份、玉竹14份、白芷17份、黄芩4份,地龙10份、蒲公英13份、回心草13份、豨莶草16份、柞蚕蛹12份、老来青16份、长杆兰7份、榼藤子6份、筋骨草5份、三张叶13份。
5.根据权利要求1所述的一种用于治疗丛集性头痛的中药组合物,其特征在于:以重量分表示,所述蛇蜕13份、护心草18份、玉竹14份、白芷9份、黄芩8份、地龙6份、蒲公英11份、回心草12份、豨莶草15份、柞蚕蛹15份、老来青15份、长杆兰8份、榼藤子8份、筋骨草7份、三张叶6份。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610975253.XA CN106389859A (zh) | 2016-11-07 | 2016-11-07 | 一种用于治疗丛集性头痛的中药组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610975253.XA CN106389859A (zh) | 2016-11-07 | 2016-11-07 | 一种用于治疗丛集性头痛的中药组合物 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106389859A true CN106389859A (zh) | 2017-02-15 |
Family
ID=58014887
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610975253.XA Withdrawn CN106389859A (zh) | 2016-11-07 | 2016-11-07 | 一种用于治疗丛集性头痛的中药组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106389859A (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103520555A (zh) * | 2013-10-27 | 2014-01-22 | 周文华 | 一种治疗偏头痛的药物 |
CN104056003A (zh) * | 2014-05-29 | 2014-09-24 | 卞永兴 | 一种治疗丛集性头痛的中药 |
CN105030928A (zh) * | 2015-07-29 | 2015-11-11 | 王璐 | 一种治疗丛集性头痛的中药及其制备方法 |
-
2016
- 2016-11-07 CN CN201610975253.XA patent/CN106389859A/zh not_active Withdrawn
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103520555A (zh) * | 2013-10-27 | 2014-01-22 | 周文华 | 一种治疗偏头痛的药物 |
CN104056003A (zh) * | 2014-05-29 | 2014-09-24 | 卞永兴 | 一种治疗丛集性头痛的中药 |
CN105030928A (zh) * | 2015-07-29 | 2015-11-11 | 王璐 | 一种治疗丛集性头痛的中药及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103977366A (zh) | 一种治疗慢性胆囊炎的药物 | |
CN104815294A (zh) | 一种治疗慢性胃炎的中药口服液及其制备方法 | |
CN1931262B (zh) | 一种治疗感冒的中药制剂 | |
CN106389859A (zh) | 一种用于治疗丛集性头痛的中药组合物 | |
CN105168628A (zh) | 一种治疗蜂窝组织炎的药物及其制备方法 | |
CN104147411A (zh) | 治疗原发性青光眼的中药制剂 | |
CN104225569A (zh) | 一种治疗慢性肠炎的中药组合物 | |
CN103977290A (zh) | 一种治疗咯血的口服中药 | |
CN107233505A (zh) | 一种用于治疗便秘的丸剂药物及其制备方法 | |
CN106266637A (zh) | 一种用于治疗偏头痛的中药组合物 | |
CN102961730B (zh) | 一种治疗消渴症的中药组合物 | |
CN106361997A (zh) | 一种用于治疗丛集性头痛的中药组合物的制备方法 | |
CN106389888A (zh) | 一种用于治疗继发性头痛的中药组合物 | |
CN103690901A (zh) | 一种治疗胆结石的中药及其制备方法 | |
CN106344706A (zh) | 一种治疗因神经痛引起头痛的中药组合物 | |
CN104288580A (zh) | 一种治疗肾炎的药物组合物 | |
CN103230505A (zh) | 一种治疗嗜食烤羊肉型脓性指头炎的中药洗剂制备方法 | |
CN103432407B (zh) | 一种治疗过食猪肝型腋下急性化脓性淋巴结炎的中药 | |
CN103432409B (zh) | 一种治疗嗜食烤肉型腋下急性化脓性淋巴结炎的中药 | |
CN103230527A (zh) | 一种治疗过食肥肉型脓性指头炎的中药洗剂制备方法 | |
CN110812466A (zh) | 一种祛湿清热的瑶药提取浓缩液的制备方法 | |
CN107929435A (zh) | 一种用于治疗痛风的胶囊剂药物及制备方法 | |
CN106728697A (zh) | 一种治疗骨关节炎的丸剂药物及其制备方法 | |
CN108159275A (zh) | 一种治疗痛风的胶囊剂药物及制备方法 | |
CN106421420A (zh) | 一种用于治疗紧张型头痛的中药组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20170215 |
|
WW01 | Invention patent application withdrawn after publication |